The total return over the past 12 months is -17.35% vs. +16.94% for the S&P 500. So far it's up -8.79% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (17.35%) | (18.38%) | (29.36%) | (16.92%) | N/A | N/A |
| Total Return CAGR | (17.35%) | (18.38%) | (29.36%) | (15.76%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
XBiotech Inc. (XBIT)
| Year | Start price | End price | XBIT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.39 | $2.18 | (8.79%) | +14.51% | (23.30%) |
| 2025 | $3.95 | $2.39 | (39.49%) | +17.72% | (57.21%) |
| 2024 | $4.00 | $3.95 | (1.25%) | +24.89% | (26.14%) |
| 2023 | $3.51 | $4.00 | +13.96% | +26.19% | (12.23%) |
| 2022 | $11.13 | $3.51 | (68.46%) | (18.17%) | (50.29%) |
| 2021 | $15.65 | $11.13 | (18.28%) | +28.74% | (47.02%) |
| 2020 | $18.67 | $15.65 | (16.15%) | +18.37% | (34.52%) |
| 2019 | $5.08 | $18.67 | +267.42% | +31.22% | +236.20% |
| 2018 | $3.94 | $5.08 | +28.93% | (4.56%) | +33.49% |
| 2017 | $10.12 | $3.94 | (61.07%) | +21.70% | (82.77%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
